首頁 › 急性雙表型白血病 › 田納西州 › Memphis
Memphis, TN 的 急性雙表型白血病 臨床試驗
7 項針對 急性雙表型白血病 的研究正在 Memphis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
招募中2 期
- Saint Jude Children's Research Hospital, Memphis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Saint Jude Children's Research Hospital, Memphis
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
招募中2 期
- St. Jude Children's Research Hospital, Memphis
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
招募中1 期
- St. Jude Children's Research Hospital, Memphis
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
招募中4 期
- St. Jude Children's Research Hospital, Memphis
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
招募中1/2 期
- Baptist Clinical Research Institute, Memphis
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- St. Jude Children's Research Hospital, Memphis
其他城市的 急性雙表型白血病 試驗
- Seattle, WA15 項研究
- Houston, TX11 項研究
- New York City, NY10 項研究
- Atlanta, GA9 項研究
- Durham, NC8 項研究
- Chicago, IL7 項研究
- Charlotte, NC6 項研究
- Baldwin Park, CA6 項研究
- Aurora, CO6 項研究
- Philadelphia, PA6 項研究
- Dallas, TX6 項研究
- Portland, OR6 項研究
Memphis 的其他研究
- 癌症（所有類型）31 項研究
- 非小細胞肺癌23 項研究
- 乳癌22 項研究
- 肺癌18 項研究
- 鐮狀細胞病18 項研究
- 急性淋巴母細胞性白血病16 項研究
- 急性髓系白血病15 項研究
- 心臟衰竭13 項研究
- 軟組織肉瘤11 項研究
- 黑色素瘤11 項研究
- 前列腺癌11 項研究
- 大腸直腸癌11 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。